428 episodi

Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.

Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.

Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.

Talking Biotech with Dr. Kevin Folta Colabra

    • Scienze
    • 4,0 • 1 valutazione

Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.

Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.

Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.

    Canadian Rules for Gene Editing - Jennifer Hubert

    Canadian Rules for Gene Editing - Jennifer Hubert

    Canada has a unique approach to plant genetic improvement that follows the product, not the process. In other words, if there is potential risk from any genetic manipulation technique, from polyploidization to transgenic to gene edits, Canadian regulators assess the relative risk in the final product. But what does the regulatory climate look like going forward as gene editing becomes more routine? Today's podcast is a conversation with Jennifer Hubert, Executive Director of Biotechnology at Crop Life Canada. 

    • 27 min
    Overcoming CAR-T Cell Bottlenecks - Dr. Andy Scharenberg

    Overcoming CAR-T Cell Bottlenecks - Dr. Andy Scharenberg

    Immunotherapy is weaponizing the body's immune system against cancer or other disease. One of the most promising approaches is CAR-T cell therapy, yet as this technology has been implemented, it's limitations have been identified. Dr. Andy Scharenberg described the current drawbacks of CAR-T cells and how his company, Umoja, is re-engineering CAR-T cells in vivo to create more effective therapies, including approaches that can address solid tumors. Co-hosted by Donald Coon. 
    www.umoja-biopharma.com

    • 46 min
    The FDA Regulatory Ecosystem- Expert Panel Discusses the Process

    The FDA Regulatory Ecosystem- Expert Panel Discusses the Process

    How do new drug applications move forward to approval?  Four experts discuss the partnership between the FDA, the drug developer, and the data needed to move a product forward. It is a surprising discussion that reveals the depth of the FDA process.  Joined by Dr. Debra Webster, Dr. Julia Marre, Dr. Michael Matthews and Dr. Jonathan Helfgott. 

    • 1h 1m
    The Psychology of Risk - Dr. Felicia Wu

    The Psychology of Risk - Dr. Felicia Wu

    We live in amazing times of technological advance, but how are the real benefits of new tech lost to an inflated sense of risk?  Dr. Felicia Wu from Michigan State University shares her expertise in describing the psychological basis of risk and applying it to questions like glyphosate and aspartame. 

    • 41 min
    Restoring the Forest with GE American Chestnut - Dr. Andy Newhouse and Erik Carlson

    Restoring the Forest with GE American Chestnut - Dr. Andy Newhouse and Erik Carlson

    This is an update on the American Chestnut Restoration Project, as discussed previously on the podcast. The American Chestnut dominated the forests of Appalachia until an imported fungus destroyed the entire range. Efforts to restore the chestnut and its ecology have employed a biotechnology approach, integrating a gene from wheat that limits the mechanism the fungus uses to attack the tree. Dr. Andy Newhouse and Erik Carlson join the podcast to discuss progress in the project.  

    • 31 min
    Addressing Disparities in Women's Healthcare - Sabrina Johnson, CEO Daré Bioscience

    Addressing Disparities in Women's Healthcare - Sabrina Johnson, CEO Daré Bioscience

    Despite being over half of the population women's health care lags behind other areas of drug development. The problem is caused by many facets, but is augmented by the fact that many of the conditions are not life threatening or are functions of aging. Sabrina Johnson, CEO of Daré Bioscience, discusses how the disparity exists, the pipeline of drugs that seek to mitigate female-specific conditions, and how smaller, leaner businesses can have significant impacts in this space. 

    • 40 min

Recensioni dei clienti

4,0 su 5
1 valutazione

1 valutazione

Gshdhrkebdidnd ,

History of crops

Great way to hear from experts about the history of crops, and how they are being improved.

Top podcast nella categoria Scienze

Geopop - Le Scienze nella vita di tutti i giorni
Geopop
Ci vuole una scienza
Il Post
Di sana pianta
Chora Media - Stefano Mancuso
A Wild Mind
Andrea Bariselli
F***ing genius
storielibere.fm
Scientificast
Scientificast

Potrebbero piacerti anche…

Business Of Biotech
Matt Pillar
The Readout Loud
STAT
The Long Run with Luke Timmerman
Timmerman Report
Raising Health
Andreessen Horowitz
Inquiring Minds
Indre Viskontas
Science Magazine Podcast
Science Magazine